Currently there is no access to CIRM clinical network in our region. CIRM CCCE award will establish this space within our geographical area as a centralized, trusted destination for patients seeking CGRMT clinical trials and in Inland Empire and Desert region of California allowing local delivery. To expand access, CCCE will enable operational improvements to accelerate FDA-authorized clinical trials involving CGRMT, allowing local delivery, with specific emphasis on CIRM-funded clinical trials. Establish capacity for local production of cell and gene therapy products that will lead to decrease the cost of centralized manufacturing and increase local access. Information exchange, and education ensuring stakeholders’ voices are integrated into decision-making.